Arena (ARNA), Orexigen (OREX) on Watch as Major PBM Adds Qsymia to Formularies List (VVUS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Express Scripts (ESRX) Deal is Huge Win for VIVUS (VVUS); Qsymia Reimbursement Will Improve
December 24, 2012 10:36 AM ESTVIVUS, Inx. (Nasdaq: VVUS) is heading in the right direction on the holiday-shortened trading session Monday following bullish comments over Qsymia reimbursement.
According to JPMorgan analyst Cory Kasimov and his team note the disclosure last week that Express Scripts (Nasdaq: ESRX) would be adding Qsymia to its national pharmacy... More
VIVUS (VVUS) Says Qsymia Now Covered by Express Scripts' (ESRX)
December 20, 2012 6:31 AM ESTVIVUS, Inc. (NASDAQ: VVUS) today announced that Express Scripts (Nasdaq: ESRX), among the country's largest Pharmacy Benefit Managers (PBMs), has added Qsymia to its national pharmacy formularies, allowing for coverage where available by benefit design of the first... More
